General Information of Drug Transporter (DT)
DT ID DTD0544 Transporter Info
Gene Name KCNA5
Transporter Name Voltage-gated potassium channel subunit Kv1.5
Gene ID
3741
UniProt ID
P22460
Post-Translational Modification of This DT
Overview of KCNA5 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-Phosphorylation X-S-nitrosylation X-S-palmitoylation X-SUMOylation X: Amino Acid

Acetylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence KCNA5 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

412

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at KCNA5 Lysine 412 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence KCNA5 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

62

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at KCNA5 Serine 62 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence KCNA5 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

127

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at KCNA5 Serine 127 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence KCNA5 [1] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

414

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at KCNA5 Serine 414 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence KCNA5 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

417

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at KCNA5 Serine 417 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence KCNA5 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

430

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at KCNA5 Serine 430 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence KCNA5 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

15

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at KCNA5 Threonine 15 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence KCNA5 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

426

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at KCNA5 Threonine 426 has the potential to affect its expression or activity.

S-nitrosylation

  Cystine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence KCNA5 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

331

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-nitrosylation at KCNA5 Cystine 331 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence KCNA5 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

346

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-nitrosylation at KCNA5 Cystine 346 has the potential to affect its expression or activity.

S-palmitoylation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence KCNA5 [9]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

604

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-palmitoylation at KCNA5 Cystine 604 has the potential to affect its expression or activity.

SUMOylation

  Lysine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Regulating the biophysical properties of the transporter [10]

Role of PTM

Properties Modulation

Modified Residue

Lysine

Modified Location

221

Related Enzyme

Small ubiquitin-related modifier 3 (SUMO3)

Experimental Method

Co-Immunoprecipitation

Detailed Description

SUMOylation at KCNA5 Lysine 221 have been reported to regulate its biophysical properties, thereby affecting its expression or activity.

  PTM Phenomenon 2

Regulating the biophysical properties of the transporter [10]

Role of PTM

Properties Modulation

Modified Residue

Lysine

Modified Location

536

Related Enzyme

Small ubiquitin-related modifier 3 (SUMO3)

Experimental Method

Co-Immunoprecipitation

Detailed Description

SUMOylation at KCNA5 Lysine 536 have been reported to regulate its biophysical properties, thereby affecting its expression or activity.
References
1 Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem. 2009 Jun 1;81(11):4493-501.
2 Global detection of protein kinase D-dependent phosphorylation events in nocodazole-treated human cells. Mol Cell Proteomics. 2012 May;11(5):160-70.
3 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
4 An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
5 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
6 A specific N-terminal residue in Kv1.5 is required for upregulation of the channel by SAP97. Biochem Biophys Res Commun. 2006 Mar 31;342(1):1-8.
7 Predict and analyze S-nitrosylation modification sites with the mRMR and IFS approaches. J Proteomics. 2012 Feb 16;75(5):1654-65.
8 Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism. Cardiovasc Res. 2006 Oct 1;72(1):80-9.
9 Posttranslational modification of voltage-dependent potassium channel Kv1.5: COOH-terminal palmitoylation modulates its biological properties. Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2012-21.
10 SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5. Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1805-10.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.